Sam S. Chang MD, MBA

Department of Urology
Patricia and Rodes Hart Professor of Urologic Surgery
Chief Surgical Officer
Vanderbilt Ingram Cancer Center
Division of Urologic Oncology

Medical School: Vanderbilt University School of Medicine
Residency: Vanderbilt University Medical Center
Fellowship: Memorial Sloan-Kettering Cancer Center
Clinical Interests: Prostate cancer, Prostatectomy, Bladder cancer, Kidney cancer, Urologic cancer

Dr. Chang, the Chief Surgical Officer at the Vanderbilt Ingram Cancer Center, formerly chaired the American Joint Committee on GU Cancer Staging Task Force and currently is the Assistant Secretary of the American Urological Association and Chair of the American Board of Urology Examination Committee responsible for board certification in the U.S

Active Clinical Trials

Altor - QUILT-3.032

A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BHG) in Combination with ALT-803 in Patients with BCG Unresponsive High-Grade Non-Muscle Invasive Bladder Cancer – CA-ALT-803-01-16.

Learn more about this trial

PI: Sam S. Chang, MD

MDx Health – PRIORITY Study

Prospective Validation of Prostate Biomarkers for Repeat Biopsy:  The PRIORITY Study.

Learn more about this study

PI: Sam S. Chang, MD